Featured Press Releases

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy

Niterra Ventures invests an additional $18M in Neoplas Med GmbH, supporting advancements in innovative cancer therapies

Niterra Ventures invests an additional $18M in Neoplas Med GmbH, supporting advancements in innovative cancer therapies

  • 26 Nov 2024

Greifswald-based medical technology pioneer Neoplas Med GmbH is intensifying its strategic...

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Mundipharma reports positive Phase III ReSPECT results for REZZAYO® (rezafungin) in preventing invasive fungal diseases in stem cell transplant patients

Mundipharma reports positive Phase III ReSPECT results for REZZAYO® (rezafungin) in preventing invasive fungal diseases in stem cell transplant patients

Leading Dermatologist Dr. Dendy Engelman Joins ELASTEN® to Advance the Future of Science-Backed Skin Health from Within

Leading Dermatologist Dr. Dendy Engelman Joins ELASTEN® to Advance the Future of Science-Backed Skin Health from Within

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

  • Dr. Oregonin Inc
  • 06 Oct 2026
SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

  • SHARx
  • 05 Oct 2026
Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

  • Aptar Pharma
  • 05 Oct 2026
Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

  • Hovione
  • 04 Oct 2026
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

  • CaseBioscience
  • 02 Oct 2026
Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

  • Ensera
  • 02 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.